Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 3
2005 7
2006 8
2007 8
2008 9
2009 7
2010 9
2011 11
2012 14
2013 7
2014 9
2015 12
2016 13
2017 12
2018 6
2019 7
2020 7
2021 8
2022 11
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Muraro E, Montico B, Lum B, Colizzi F, Giurato G, Salvati A, Guerrieri R, Rizzo A, Comaro E, Canzonieri V, Anichini A, Del Vecchio M, Mortarini R, Milione M, Weisz A, Pizzichetta MA, Simpson F, Dolcetti R, Fratta E, Sigalotti L. Muraro E, et al. Among authors: dolcetti r. Front Immunol. 2024 Mar 6;15:1336566. doi: 10.3389/fimmu.2024.1336566. eCollection 2024. Front Immunol. 2024. PMID: 38510242 Free PMC article.
Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro.
Montico B, Nigro A, Lamberti MJ, Martorelli D, Mastorci K, Ravo M, Giurato G, Steffan A, Dolcetti R, Casolaro V, Dal Col J. Montico B, et al. Among authors: dolcetti r. Cytotherapy. 2024 Feb;26(2):145-156. doi: 10.1016/j.jcyt.2023.11.014. Epub 2023 Dec 14. Cytotherapy. 2024. PMID: 38099895 Free article.
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Lonie JM, Brosda S, Bonazzi VF, Aoude LG, Patel K, Brown I, Sharma S, Lampe G, Addala V, Koufariotis LT, Wood S, Waddell N, Dolcetti R, Barbour AP. Lonie JM, et al. Among authors: dolcetti r. Front Immunol. 2023 Oct 12;14:1220129. doi: 10.3389/fimmu.2023.1220129. eCollection 2023. Front Immunol. 2023. PMID: 37965317 Free PMC article.
Method optimisation to enrich small extracellular vesicles from saliva samples.
Jangholi A, Bark JM, Trevisan França de Lima L, Lima LG, Möller A, Kenny L, Vasani S, Rao S, Dolcetti R, Punyadeera C. Jangholi A, et al. Among authors: dolcetti r. Clin Transl Med. 2023 Aug;13(8):e1341. doi: 10.1002/ctm2.1341. Clin Transl Med. 2023. PMID: 37587263 Free PMC article. No abstract available.
LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
Casarotto M, Lupato V, Giurato G, Guerrieri R, Sulfaro S, Salvati A, D'Angelo E, Furlan C, Menegaldo A, Baboci L, Montico B, Turturici I, Dolcetti R, Romeo S, Baggio V, Corrado S, Businello G, Guido M, Weisz A, Giacomarra V, Franchin G, Steffan A, Sigalotti L, Vaccher E, Boscolo-Rizzo P, Jerry P, Fanetti G, Fratta E. Casarotto M, et al. Among authors: dolcetti r. Clin Epigenetics. 2022 Dec 12;14(1):171. doi: 10.1186/s13148-022-01386-5. Clin Epigenetics. 2022. PMID: 36503584 Free PMC article.
174 results